Traditional Chinese Medicine and regulatory roles on epithelial-mesenchymal transitions
Author(s)
Bai, Jing; Kwok, Wee C; Thiery, Jean-Paul
Download13020_2019_Article_257.pdf (1.367Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Epithelial–mesenchymal transition (EMT) is a critical biological process allowing epithelial cells to de-differentiate into mesenchymal cells. Orchestrated signaling pathways cooperatively induce EMT and effect physiological, sometimes pathological outcomes. Traditional Chinese Medicine (TCM) has been clinically prescribed for thousands of years and recent studies have found that TCM therapies can participate in EMT regulation. In this review, the historical discovery of EMT will be introduced, followed by a brief overview of its major roles in development and diseases. The second section will focus on EMT in organ fibrosis and tissue regeneration. The third section discusses EMT-induced cancer metastasis, and details how EMT contribute to distant dissemination. Finally, new EMT players are described, namely microRNA, epigenetic modifications, and alternative splicing. TCM drugs that affect EMT proven through an evidence-based research approach will be presented in each section.
Date issued
2019-09-23Department
Massachusetts Institute of Technology. Department of Mechanical EngineeringJournal
Chinese Medicine
Publisher
BioMed Central
Citation
Bai, Jing, Wee C Kwok, and Jean-Paul Thiery. "Traditional Chinese Medicine and regulatory roles on epithelial-mesenchymal transitions." Chinese Medicine 14 (Sept. 2019): no. 34 doi 10.1186/s13020-019-0257-6 ©2019 Author(s)
Version: Final published version
ISSN
1749-8546